Related Experiment Video
Updated: Jul 10, 2026
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy]
J J Barbón1, J González-Tuero, L L Gay
1Hospital San Agustín de Avilés, Asturias, Spain. jjbarbon@telecable.es
Case Report:
We report a case of a patient diagnosed with prostatic adenocarcinoma with multiple bone metastases and a choroidal metastasis in his left eye. Hormonal therapy with an anti-androgen and a LH-RH agonist was followed by regression of the choroidal mass over a period of 2 months. No metastatic recurrence has been demonstrated after a follow-up period of 14 months.
Discussion:
Complete resolution of choroidal metastases of prostatic adenocarcinoma with hormonal therapy is exceptional, but the effect of this treatment on such metastases should be observed before recommending radiation therapy.
